首页 > 最新文献

General Thoracic and Cardiovascular Surgery最新文献

英文 中文
Comments on "The outcome of extracardiac lateral tunnel total cavopulmonary connection with growing conduit using expanded polytetrafuoroethylene graft". 关于“扩展聚四氟乙烯移植物用于生长导管的心外外侧隧道全腔肺连接的效果”的评论。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2025-11-29 DOI: 10.1007/s11748-025-02234-y
Memuna Jehan Zeb, Anum Choudhry, Armoghan Ayub, Saba Mushtaq, Numan Abdullah
{"title":"Comments on \"The outcome of extracardiac lateral tunnel total cavopulmonary connection with growing conduit using expanded polytetrafuoroethylene graft\".","authors":"Memuna Jehan Zeb, Anum Choudhry, Armoghan Ayub, Saba Mushtaq, Numan Abdullah","doi":"10.1007/s11748-025-02234-y","DOIUrl":"10.1007/s11748-025-02234-y","url":null,"abstract":"","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"324-325"},"PeriodicalIF":1.3,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145632273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Temporary chest closure and open chest management for severe chest trauma: a retrospective study of 10 cases at a single hospital. 临时闭胸和开胸治疗严重胸外伤:对一家医院10例病例的回顾性研究
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2025-09-16 DOI: 10.1007/s11748-025-02200-8
Hiroyuki Kayata, Akihiro Usui, Koki Terakawa, Koichi Inukai, Yu Hashimoto, Fumitaka Kato, Koji Amano, Nobutaka Mukai, Naoki Shinyama, Masanori Morita

Objectives: Evidence to establish standardized damage control surgery for severe chest trauma is insufficient. Therefore, we aimed to evaluate the outcomes, complications, effectiveness, and safety of temporary chest closure and open chest management in our hospital.

Methods: We retrospectively reviewed the backgrounds and perioperative outcomes of 10 patients who underwent open chest management with temporary chest closure for severe trauma at our hospital from January 2015 to June 2024 using their medical records.

Results: The median patient age was 54 years, nine patients had blunt multiple trauma, and one patient had an isolated, penetrating chest injury. All patients had hemorrhagic shock upon arrival: the median chest Abbreviated Injury Scale score and Injury Severity Score were 4.5 and 30, respectively. The initial chest surgery was thoracotomy-based hemostasis for injuries of the chest wall, lungs, heart, and great vessels in six cases, and pulmonary resection for lung injury in four cases; all cases involved open chest management with temporary chest closure after intrapleural gauze packing. The median operative time and intraoperative bleeding was 72 min and 1710 mL, respectively. Seven of the 10 patients survived, with a median open chest management period of 2 days, with no postoperative empyema or wound infection.

Conclusion: Open chest management with temporary chest closure for severe chest trauma is useful for the prompt completion of the initial chest surgery and initiation of treatment for concomitant injuries and resuscitation in the intensive care unit.

目的:建立标准化的损伤控制手术治疗严重胸外伤的证据不足。因此,我们旨在评估我院临时闭胸和开胸处理的结局、并发症、有效性和安全性。方法:回顾性分析2015年1月至2024年6月我院收治的10例重症外伤患者的背景及围手术期结局。结果:患者年龄中位数为54岁,9例患者有钝性多发创伤,1例患者有孤立的穿透性胸部损伤。所有患者到达时均发生失血性休克:胸部简易损伤量表评分中位数为4.5分,损伤严重程度评分中位数为30分。最初的胸部手术是6例胸壁、肺、心脏和大血管损伤的开胸止血,4例肺损伤的肺切除术;所有病例均采用胸腔内纱布填塞后开胸临时闭胸。中位手术时间72 min,术中出血1710 mL。10例患者中有7例存活,中位开胸管理时间为2天,无术后脓胸或伤口感染。结论:在重症监护室对严重胸外伤进行开胸临时闭胸处理,有利于及时完成初始胸部手术,及时开始对伴发损伤的治疗和复苏。
{"title":"Temporary chest closure and open chest management for severe chest trauma: a retrospective study of 10 cases at a single hospital.","authors":"Hiroyuki Kayata, Akihiro Usui, Koki Terakawa, Koichi Inukai, Yu Hashimoto, Fumitaka Kato, Koji Amano, Nobutaka Mukai, Naoki Shinyama, Masanori Morita","doi":"10.1007/s11748-025-02200-8","DOIUrl":"10.1007/s11748-025-02200-8","url":null,"abstract":"<p><strong>Objectives: </strong>Evidence to establish standardized damage control surgery for severe chest trauma is insufficient. Therefore, we aimed to evaluate the outcomes, complications, effectiveness, and safety of temporary chest closure and open chest management in our hospital.</p><p><strong>Methods: </strong>We retrospectively reviewed the backgrounds and perioperative outcomes of 10 patients who underwent open chest management with temporary chest closure for severe trauma at our hospital from January 2015 to June 2024 using their medical records.</p><p><strong>Results: </strong>The median patient age was 54 years, nine patients had blunt multiple trauma, and one patient had an isolated, penetrating chest injury. All patients had hemorrhagic shock upon arrival: the median chest Abbreviated Injury Scale score and Injury Severity Score were 4.5 and 30, respectively. The initial chest surgery was thoracotomy-based hemostasis for injuries of the chest wall, lungs, heart, and great vessels in six cases, and pulmonary resection for lung injury in four cases; all cases involved open chest management with temporary chest closure after intrapleural gauze packing. The median operative time and intraoperative bleeding was 72 min and 1710 mL, respectively. Seven of the 10 patients survived, with a median open chest management period of 2 days, with no postoperative empyema or wound infection.</p><p><strong>Conclusion: </strong>Open chest management with temporary chest closure for severe chest trauma is useful for the prompt completion of the initial chest surgery and initiation of treatment for concomitant injuries and resuscitation in the intensive care unit.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"295-300"},"PeriodicalIF":1.3,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12957619/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145069588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of posterior pericardiotomy on atrial fibrillation in minimally invasive direct coronary artery bypass surgery. 文献名称:微创直接冠状动脉搭桥手术中后路心包切开术对房颤的影响。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2025-09-26 DOI: 10.1007/s11748-025-02204-4
Cüneyt Narin, Mustafa Barış Kemahlı

Objective: Posterior pericardiotomy can be performed after cardiac surgery to drain pericardial fluid and reduce the incidence of postoperative atrial fibrillation. However, the effect of posterior pericardiotomy in minimally invasive direct coronary artery bypass surgery on the development of postoperative atrial fibrillation remains unknown.

Methods: The patients included in our study underwent complete revascularization through left anterior thoracotomy under cardiopulmonary bypass, using X-clamp and cardioplegia, without any limitations on coronary lesion type or localization. Patients who underwent minimally invasive direct coronary artery bypass were retrospectively divided into two groups: the control group, consisting of patients who did not undergo posterior pericardiotomy, and the posterior pericardiotomy group, consisting of patients who underwent posterior pericardiotomy after this date. The two groups were retrospectively compared in terms of postoperative atrial fibrillation development, the day of left thoracic drain removal, and clinical characteristics.

Results: Lower development of atrial fibrillation was observed in the posterior pericardiotomy group (n = 10, 13.3%) compared to the control group (n = 20, 30.3%) (p = 0.024). When comparing the days of drain removal, the left thoracic drain was removed later in the patients in the posterior pericardiotomy group compared to the control group (3.2 ± 1.18, 2.6 ± 0.96, p = 0.007). There was no difference between the groups in terms of patient characteristics compared (p > 0.05).

Conclusion: In this revascularization technique, where the left-sided pericardiotomy is partially closed to prevent cardiac herniation, posterior pericardiotomy may help prevent the development of postoperative atrial fibrillation by facilitating the drainage of pericardial fluid.

目的:心脏术后可行后路心包切开术,引流心包积液,减少术后房颤的发生。然而,微创直接冠状动脉搭桥手术后心包切开术对术后房颤发生的影响尚不清楚。方法:本研究纳入的患者在体外循环下经左前开胸行完全血运重建术,使用X-clamp和心脏截瘫,冠状动脉病变类型和部位不受限制。行微创直接冠状动脉搭桥术的患者回顾性分为两组:对照组,包括未行后路心包切开术的患者;后路心包切开术组,包括在该日期后行后路心包切开术的患者。回顾性比较两组患者术后房颤发生情况、左胸引流术时间及临床特点。结果:后路心包切开术组房颤发生率(n = 10, 13.3%)低于对照组(n = 20, 30.3%) (p = 0.024)。比较引流天数时,后路心包切开术组患者左胸引流时间较对照组晚(3.2±1.18,2.6±0.96,p = 0.007)。两组患者特征比较无差异(p < 0.05)。结论:在这种血运重建术中,左侧心包切开术部分关闭以防止心脏疝,后路心包切开术可通过促进心包液的引流来预防术后房颤的发生。
{"title":"Effect of posterior pericardiotomy on atrial fibrillation in minimally invasive direct coronary artery bypass surgery.","authors":"Cüneyt Narin, Mustafa Barış Kemahlı","doi":"10.1007/s11748-025-02204-4","DOIUrl":"10.1007/s11748-025-02204-4","url":null,"abstract":"<p><strong>Objective: </strong>Posterior pericardiotomy can be performed after cardiac surgery to drain pericardial fluid and reduce the incidence of postoperative atrial fibrillation. However, the effect of posterior pericardiotomy in minimally invasive direct coronary artery bypass surgery on the development of postoperative atrial fibrillation remains unknown.</p><p><strong>Methods: </strong>The patients included in our study underwent complete revascularization through left anterior thoracotomy under cardiopulmonary bypass, using X-clamp and cardioplegia, without any limitations on coronary lesion type or localization. Patients who underwent minimally invasive direct coronary artery bypass were retrospectively divided into two groups: the control group, consisting of patients who did not undergo posterior pericardiotomy, and the posterior pericardiotomy group, consisting of patients who underwent posterior pericardiotomy after this date. The two groups were retrospectively compared in terms of postoperative atrial fibrillation development, the day of left thoracic drain removal, and clinical characteristics.</p><p><strong>Results: </strong>Lower development of atrial fibrillation was observed in the posterior pericardiotomy group (n = 10, 13.3%) compared to the control group (n = 20, 30.3%) (p = 0.024). When comparing the days of drain removal, the left thoracic drain was removed later in the patients in the posterior pericardiotomy group compared to the control group (3.2 ± 1.18, 2.6 ± 0.96, p = 0.007). There was no difference between the groups in terms of patient characteristics compared (p > 0.05).</p><p><strong>Conclusion: </strong>In this revascularization technique, where the left-sided pericardiotomy is partially closed to prevent cardiac herniation, posterior pericardiotomy may help prevent the development of postoperative atrial fibrillation by facilitating the drainage of pericardial fluid.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"240-244"},"PeriodicalIF":1.3,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145148819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of physiotherapy on breathing cycle after thoracic surgery measured with impedance pneumography in a prospective clinical comparison. 在前瞻性临床比较中,阻抗肺造影术测量物理治疗对胸外科术后呼吸周期的影响。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2025-09-26 DOI: 10.1007/s11748-025-02199-y
Sabina Lähteenmäki, Milla Juutinen, Jari Viik, Heidi Mahrberg, Jari Laurikka

Objectives: Impedance pneumography (IP) records respiratory cycle and provides non-invasive means to evaluate changes after thoracic surgery. This comparative study evaluated if changes after thoracic surgery can be modified by two pulmonary rehabilitation modalities.

Methods: 88 patients undergoing thoracic surgery were randomly allocated to either positive expiratory pressure (PEP) or inspiratory muscle training (IMT) physiotherapy group. Physiotherapy was performed and IP recorded preoperatively and at first and second postoperative days (POD1 and POD2) during tidal breathing. Full three timepoint IP data were collected from 81 patients (42 in the PEP group, 39 in the IMT group). Average inspiration and expiration time in seconds (TinspAvg and TexpAvg) and average breathing frequencies (BrthFreqAvg) were calculated from a 10-min measurement period and assessed as primary outcomes. Results were also assessed in blocks of different surgical techniques (thoracotomy or VATS) and the extent of surgery (pulmonary resection or minor thoracic operation).

Results: TinspAvg and TexpAvg decreased after surgery but started to increase in the IMT group between POD1 and POD2 with no significant difference compared to PEP group. Among patients operated with thoracotomy TexpAvg was slightly but insignificantly higher in the IMT group at POD2. The ratio between the time of expiration and the time of inspiration (EI ratio) was significantly higher in the IMT group with thoracotomy (difference between groups over three timepoints, (p = 0.044) and at POD1 (p = 0.015)).

Conclusions: IMT seemed to enhance expiration specifically among thoracotomy patients and thus may provide means for enhancing the recovery after thoracic operations.

Clinical trial registration: NCT02931617/U.S. National Library of Medicine, ClinicalTrials.gov.

目的:阻抗肺造影术(IP)记录呼吸周期,并提供无创方法评估胸外科手术后的变化。这项比较研究评估了两种肺部康复方式是否可以改善胸外科手术后的变化。方法:88例胸外科手术患者随机分为呼气正压(PEP)组和吸气肌训练(IMT)物理治疗组。进行物理治疗并记录术前及术后第1天和第2天(POD1和POD2)潮汐呼吸时的IP。从81例患者(PEP组42例,IMT组39例)中收集了完整的三个时间点IP数据。平均吸气和呼气时间(以秒为单位)(TinspAvg和TexpAvg)和平均呼吸频率(BrthFreqAvg)从10分钟的测量周期计算,并作为主要结果进行评估。结果还评估了不同手术技术(开胸或VATS)和手术范围(肺切除或小胸手术)的块。结果:在POD1和POD2之间,IMT组TinspAvg和TexpAvg术后下降,但开始升高,与PEP组比较差异无统计学意义。在开胸患者中,TexpAvg在POD2时IMT组稍高但不显著。IMT加开胸组呼气时间与吸气时间之比(EI比)显著高于对照组(3个时间点组间差异(p = 0.044)和POD1时组间差异(p = 0.015)。结论:IMT似乎在开胸手术患者中特异性地提高了呼气,因此可能为提高胸外科手术后的恢复提供了手段。临床试验注册:NCT02931617/U.S.国家医学图书馆,ClinicalTrials.gov。
{"title":"Effects of physiotherapy on breathing cycle after thoracic surgery measured with impedance pneumography in a prospective clinical comparison.","authors":"Sabina Lähteenmäki, Milla Juutinen, Jari Viik, Heidi Mahrberg, Jari Laurikka","doi":"10.1007/s11748-025-02199-y","DOIUrl":"10.1007/s11748-025-02199-y","url":null,"abstract":"<p><strong>Objectives: </strong>Impedance pneumography (IP) records respiratory cycle and provides non-invasive means to evaluate changes after thoracic surgery. This comparative study evaluated if changes after thoracic surgery can be modified by two pulmonary rehabilitation modalities.</p><p><strong>Methods: </strong>88 patients undergoing thoracic surgery were randomly allocated to either positive expiratory pressure (PEP) or inspiratory muscle training (IMT) physiotherapy group. Physiotherapy was performed and IP recorded preoperatively and at first and second postoperative days (POD1 and POD2) during tidal breathing. Full three timepoint IP data were collected from 81 patients (42 in the PEP group, 39 in the IMT group). Average inspiration and expiration time in seconds (TinspAvg and TexpAvg) and average breathing frequencies (BrthFreqAvg) were calculated from a 10-min measurement period and assessed as primary outcomes. Results were also assessed in blocks of different surgical techniques (thoracotomy or VATS) and the extent of surgery (pulmonary resection or minor thoracic operation).</p><p><strong>Results: </strong>TinspAvg and TexpAvg decreased after surgery but started to increase in the IMT group between POD1 and POD2 with no significant difference compared to PEP group. Among patients operated with thoracotomy TexpAvg was slightly but insignificantly higher in the IMT group at POD2. The ratio between the time of expiration and the time of inspiration (EI ratio) was significantly higher in the IMT group with thoracotomy (difference between groups over three timepoints, (p = 0.044) and at POD1 (p = 0.015)).</p><p><strong>Conclusions: </strong>IMT seemed to enhance expiration specifically among thoracotomy patients and thus may provide means for enhancing the recovery after thoracic operations.</p><p><strong>Clinical trial registration: </strong>NCT02931617/U.S. National Library of Medicine, ClinicalTrials.gov.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"286-294"},"PeriodicalIF":1.3,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12956966/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145148682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The outcome of extracardiac lateral tunnel total cavopulmonary connection with growing conduit using expanded polytetrafluoroethylene graft. 扩展聚四氟乙烯移植物用于生长导管的心外外侧隧道全腔肺连接的效果。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2025-09-29 DOI: 10.1007/s11748-025-02206-2
Hironobu Nishiori, Mitsuru Aoki, Ikuo Hagino, Kentaro Umezu, Hiroshi Koshiyama, Takahiro Ito

Objectives: We sought to examine long-term results of the total cavopulmonary connection with an extracardiac lateral tunnel using expanded polytetrafluoroethylene graft and the outside of right atrial wall, with special attention to angiographic evaluation of serial changes of the tunnel geometry.

Methods: Of 113 patients subjected to the Fontan operation between April 2003 and April 2022, 65 patients who opted for the extracardiac lateral tunnel technique were retrospectively analyzed. Of these, 35 patients who had at least two postoperative catheterizations (mean 0.7 ± 0.4 and 6.6 ± 3.5 years post-op) were analyzed for changes in tunnel diameter.

Results: There was one case (1.5%) of 30-day death, and three late deaths. The cumulative survival rate at 14 years after the surgery was 91.2%. There was one case (1.5%) which required conversion to total cavopulmonary connection with an extracardiac conduit. Angiographically, Fontan route diameter increased significantly at both the level of inferior vena cava anastomosis (11.0 ± 2.4 to 14.9 ± 3.4 mm, P < 0.001), the middle level of Fontan route (11.0 ± 2.5 to 12.9 ± 3.2 mm, P < 0.001), and the level of pulmonary artery anastomosis (10.0 ± 2.5 to 13.6 ± 4.9 mm, P < 0.001), whereas the diameter indexed to the normal inferior vena cava remained over 100%.

Conclusions: Long-term results of the Fontan operation with extracardiac lateral tunnel using half cut expanded polytetrafluoroethylene graft and outside of the right atrium were favorable. Proportional increase of conduit size was demonstrated, suggesting a potential of the conduit to grow and that the growth might correlate with somatic growth.

目的:我们试图检查使用扩张聚四氟乙烯移植物和右心房壁外的全腔室肺连接与心外外侧隧道的长期结果,特别关注隧道几何形状的一系列变化的血管造影评估。方法:回顾性分析2003年4月至2022年4月行Fontan手术的113例患者,其中65例采用心外外侧隧道技术。其中,35例术后至少进行两次导管插入术的患者(平均术后0.7±0.4年和6.6±3.5年)进行隧道直径变化分析。结果:30天死亡1例(1.5%),晚期死亡3例。术后14年的累计生存率为91.2%。有1例(1.5%)需要转换为经心外导管的全腔静脉肺连接。下腔静脉吻合口水平Fontan径线均明显增大(11.0±2.4 ~ 14.9±3.4 mm), P结论:半切扩张聚四氟乙烯移植心外侧管Fontan手术及右心房外侧管远期效果良好。导管大小成比例增加,表明导管具有生长潜力,其生长可能与体细胞生长有关。
{"title":"The outcome of extracardiac lateral tunnel total cavopulmonary connection with growing conduit using expanded polytetrafluoroethylene graft.","authors":"Hironobu Nishiori, Mitsuru Aoki, Ikuo Hagino, Kentaro Umezu, Hiroshi Koshiyama, Takahiro Ito","doi":"10.1007/s11748-025-02206-2","DOIUrl":"10.1007/s11748-025-02206-2","url":null,"abstract":"<p><strong>Objectives: </strong>We sought to examine long-term results of the total cavopulmonary connection with an extracardiac lateral tunnel using expanded polytetrafluoroethylene graft and the outside of right atrial wall, with special attention to angiographic evaluation of serial changes of the tunnel geometry.</p><p><strong>Methods: </strong>Of 113 patients subjected to the Fontan operation between April 2003 and April 2022, 65 patients who opted for the extracardiac lateral tunnel technique were retrospectively analyzed. Of these, 35 patients who had at least two postoperative catheterizations (mean 0.7 ± 0.4 and 6.6 ± 3.5 years post-op) were analyzed for changes in tunnel diameter.</p><p><strong>Results: </strong>There was one case (1.5%) of 30-day death, and three late deaths. The cumulative survival rate at 14 years after the surgery was 91.2%. There was one case (1.5%) which required conversion to total cavopulmonary connection with an extracardiac conduit. Angiographically, Fontan route diameter increased significantly at both the level of inferior vena cava anastomosis (11.0 ± 2.4 to 14.9 ± 3.4 mm, P < 0.001), the middle level of Fontan route (11.0 ± 2.5 to 12.9 ± 3.2 mm, P < 0.001), and the level of pulmonary artery anastomosis (10.0 ± 2.5 to 13.6 ± 4.9 mm, P < 0.001), whereas the diameter indexed to the normal inferior vena cava remained over 100%.</p><p><strong>Conclusions: </strong>Long-term results of the Fontan operation with extracardiac lateral tunnel using half cut expanded polytetrafluoroethylene graft and outside of the right atrium were favorable. Proportional increase of conduit size was demonstrated, suggesting a potential of the conduit to grow and that the growth might correlate with somatic growth.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"253-261"},"PeriodicalIF":1.3,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145191410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of prognostic factors after pulmonary resection for metastatic breast cancer: a 23-year single-institution retrospective study. 转移性乳腺癌肺切除术后预后因素分析:一项为期23年的单机构回顾性研究。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2025-10-16 DOI: 10.1007/s11748-025-02207-1
Ryusei Yoshino, Kengo Takahashi, Nozomi Hatanaka, Akane Ito, Nanami Ujiie, Shunsuke Yasuda, Masahiro Kitada

Objectives: Recent advances in therapeutics have substantially improved breast cancer treatment outcomes. However, data on prognostic factors after surgical resection of pulmonary metastases from breast cancer remain limited.

Methods: This single-center retrospective study analyzed data from patients with breast cancer who had undergone pulmonary metastasectomy between 2000 and 2023. We reviewed clinical and pathological parameters, including the disease-free interval (DFI), size and number of pulmonary metastases.

Results: This study included 33 patients. The median postoperative survival of breast cancer patients with lung metastasis was 40 (range 4-217) months. According to univariate analysis, hormone receptor-positive breast cancer, pStage I or II breast cancer, lung metastases < 20 mm, hormone receptor-positive lung metastases, absence of other metastases, and DFI ≥ 24 months were significantly associated with better survival. Multivariate analysis identified DFI < 24 months (hazard ratio [HR] 9.520, 95% confidence interval [CI] 2.158-27.070) and tumor size ≥ 20 mm (HR 4.958, 95% CI 1.290-27.550) independently predicted poorer survival; ≥ 2 metastatic lesions showed a non-significant trend toward worse outcomes (HR 3.272, 95% CI 0.913-11.090).

Conclusions: This study clarified the criteria for pulmonary metastasectomy in patients with breast cancer. Considering subtype changes between the primary tumor and metastases could enable personalized therapies.

目的:治疗学的最新进展大大改善了乳腺癌的治疗效果。然而,关于乳腺癌肺转移灶手术切除后预后因素的数据仍然有限。方法:这项单中心回顾性研究分析了2000年至2023年间接受肺转移切除术的乳腺癌患者的数据。我们回顾了临床和病理参数,包括无病间期(DFI),肺转移的大小和数量。结果:本研究纳入33例患者。肺癌转移患者术后中位生存期为40个月(范围4-217)。单因素分析,激素受体阳性乳腺癌,pi期或II期乳腺癌,肺转移结论:本研究明确了乳腺癌患者肺转移切除术的标准。考虑原发肿瘤和转移瘤之间的亚型变化可以实现个性化治疗。
{"title":"Analysis of prognostic factors after pulmonary resection for metastatic breast cancer: a 23-year single-institution retrospective study.","authors":"Ryusei Yoshino, Kengo Takahashi, Nozomi Hatanaka, Akane Ito, Nanami Ujiie, Shunsuke Yasuda, Masahiro Kitada","doi":"10.1007/s11748-025-02207-1","DOIUrl":"10.1007/s11748-025-02207-1","url":null,"abstract":"<p><strong>Objectives: </strong>Recent advances in therapeutics have substantially improved breast cancer treatment outcomes. However, data on prognostic factors after surgical resection of pulmonary metastases from breast cancer remain limited.</p><p><strong>Methods: </strong>This single-center retrospective study analyzed data from patients with breast cancer who had undergone pulmonary metastasectomy between 2000 and 2023. We reviewed clinical and pathological parameters, including the disease-free interval (DFI), size and number of pulmonary metastases.</p><p><strong>Results: </strong>This study included 33 patients. The median postoperative survival of breast cancer patients with lung metastasis was 40 (range 4-217) months. According to univariate analysis, hormone receptor-positive breast cancer, pStage I or II breast cancer, lung metastases < 20 mm, hormone receptor-positive lung metastases, absence of other metastases, and DFI ≥ 24 months were significantly associated with better survival. Multivariate analysis identified DFI < 24 months (hazard ratio [HR] 9.520, 95% confidence interval [CI] 2.158-27.070) and tumor size ≥ 20 mm (HR 4.958, 95% CI 1.290-27.550) independently predicted poorer survival; ≥ 2 metastatic lesions showed a non-significant trend toward worse outcomes (HR 3.272, 95% CI 0.913-11.090).</p><p><strong>Conclusions: </strong>This study clarified the criteria for pulmonary metastasectomy in patients with breast cancer. Considering subtype changes between the primary tumor and metastases could enable personalized therapies.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"309-316"},"PeriodicalIF":1.3,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145299653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Effect of posterior pericardiotomy on atrial fibrillation in minimally invasive direct coronary artery bypass surgery. 纠正:微创直接冠状动脉搭桥手术后心包切开术对房颤的影响。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 DOI: 10.1007/s11748-025-02215-1
Cüneyt Narin, Mustafa Barış Kemahlı
{"title":"Correction: Effect of posterior pericardiotomy on atrial fibrillation in minimally invasive direct coronary artery bypass surgery.","authors":"Cüneyt Narin, Mustafa Barış Kemahlı","doi":"10.1007/s11748-025-02215-1","DOIUrl":"10.1007/s11748-025-02215-1","url":null,"abstract":"","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"245"},"PeriodicalIF":1.3,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145336659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New risk model for prognostic prediction after surgical aortic valve replacement in hemodialysis patients. 血液透析患者主动脉瓣置换术后预测预后的新风险模型。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2025-11-04 DOI: 10.1007/s11748-025-02205-3
Shohei Yamada, Koichi Maeda, Kyongsun Pak, Koichi Inoue, Ai Kawamura, Kizuku Yamashita, Daisuke Yoshioka, Kazuo Shimamura, Shigeru Miyagawa

Objective(s): Due to the poor prognosis of dialysis patients, accurately predicting life expectancy after aortic stenosis surgery remains challenging, leading to potential misselection of treatment options. This study aimed to develop a prognostic model specific to dialysis patients to facilitate individualized treatment selection.

Methods: A total of 171 dialysis patients with aortic stenosis who underwent initial isolated surgical aortic valve replacement at seven cardiovascular centers in Japan between 2011 and 2021 were enrolled. The cohort was randomly divided into the training and validation cohorts in a 2:1 ratio. Risk factors contributing to mortality were identified from preoperative variables, and a prognostic model was developed using the Cox proportional hazards model.

Results: Among the 171 patients, 88 deaths occurred during the total observation period of 488.9 person-years. The cumulative overall survival rates at 1, 3, and 5 years, estimated using the Kaplan-Meier method, were 74.7%, 59.4%, and 38.7%, respectively. An optimal risk model was developed, incorporating six factors: age, serum albumin, peripheral artery disease, sex, insulin-dependent diabetes mellitus, and atrial fibrillation. The model demonstrated strong predictive accuracy, with a 5-year C-statistic of 0.723 (95% confidence interval: 0.658-0.788) and 0.656 (95% confidence interval: 0.543-0.770) in the training and validation cohorts, respectively. Calibration plots confirmed that actual survival up to 5 years was well predicted (intraclass correlation coefficient = 0.918, 95% confidence interval: 0.703-0.981).

Conclusions: The proposed model is a reliable prognostic tool for dialysis patients who underwent surgical aortic valve replacement.

目的:由于透析患者的预后较差,准确预测主动脉瓣狭窄手术后的预期寿命仍然具有挑战性,导致治疗方案的潜在错误选择。本研究旨在建立一种针对透析患者的预后模型,以促进个体化治疗选择。方法:在2011年至2021年期间,在日本7个心血管中心接受首次孤立主动脉瓣置换术的171例主动脉瓣狭窄透析患者被纳入研究。该队列按2:1的比例随机分为训练组和验证组。从术前变量中确定导致死亡的危险因素,并使用Cox比例风险模型建立预后模型。结果:在488.9人年的总观察期内,171例患者中有88例死亡。使用Kaplan-Meier法估计的1,3,5年累积总生存率分别为74.7%,59.4%和38.7%。建立了一个最优风险模型,包括六个因素:年龄、血清白蛋白、外周动脉疾病、性别、胰岛素依赖型糖尿病和心房颤动。该模型具有较强的预测准确性,训练组和验证组的5年c统计量分别为0.723(95%置信区间:0.658-0.788)和0.656(95%置信区间:0.543-0.770)。校正图证实实际生存期可达5年(类内相关系数= 0.918,95%可信区间:0.703-0.981)。结论:该模型对于接受主动脉瓣置换术的透析患者是一种可靠的预后工具。
{"title":"New risk model for prognostic prediction after surgical aortic valve replacement in hemodialysis patients.","authors":"Shohei Yamada, Koichi Maeda, Kyongsun Pak, Koichi Inoue, Ai Kawamura, Kizuku Yamashita, Daisuke Yoshioka, Kazuo Shimamura, Shigeru Miyagawa","doi":"10.1007/s11748-025-02205-3","DOIUrl":"10.1007/s11748-025-02205-3","url":null,"abstract":"<p><strong>Objective(s): </strong>Due to the poor prognosis of dialysis patients, accurately predicting life expectancy after aortic stenosis surgery remains challenging, leading to potential misselection of treatment options. This study aimed to develop a prognostic model specific to dialysis patients to facilitate individualized treatment selection.</p><p><strong>Methods: </strong>A total of 171 dialysis patients with aortic stenosis who underwent initial isolated surgical aortic valve replacement at seven cardiovascular centers in Japan between 2011 and 2021 were enrolled. The cohort was randomly divided into the training and validation cohorts in a 2:1 ratio. Risk factors contributing to mortality were identified from preoperative variables, and a prognostic model was developed using the Cox proportional hazards model.</p><p><strong>Results: </strong>Among the 171 patients, 88 deaths occurred during the total observation period of 488.9 person-years. The cumulative overall survival rates at 1, 3, and 5 years, estimated using the Kaplan-Meier method, were 74.7%, 59.4%, and 38.7%, respectively. An optimal risk model was developed, incorporating six factors: age, serum albumin, peripheral artery disease, sex, insulin-dependent diabetes mellitus, and atrial fibrillation. The model demonstrated strong predictive accuracy, with a 5-year C-statistic of 0.723 (95% confidence interval: 0.658-0.788) and 0.656 (95% confidence interval: 0.543-0.770) in the training and validation cohorts, respectively. Calibration plots confirmed that actual survival up to 5 years was well predicted (intraclass correlation coefficient = 0.918, 95% confidence interval: 0.703-0.981).</p><p><strong>Conclusions: </strong>The proposed model is a reliable prognostic tool for dialysis patients who underwent surgical aortic valve replacement.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"246-252"},"PeriodicalIF":1.3,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145437947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood loss and prolonged air leak reduction by applying TenaTac® gelatine patch after major pulmonary minimal-invasive resection. 大肺微创切除术后应用TenaTac®明胶贴片减少失血和延长空气泄漏。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2025-09-10 DOI: 10.1007/s11748-025-02194-3
Caroline Rivera, Cyril Perrot, Florence Mazeres, Elodie Rive

Objective: Reduction of bleeding and prolonged air leak (>5 days) following major lung resection remains a challenge. Hemostasis and aerostasis devices can facilitate earlier pleural de-drainage and fast-track. Our objectives were to evaluate the efficacy of TenaTac® (an elastic, adhering patch approved as a medical device) in reducing bleeding and prolonged air leak after major lung resection.

Methods: This monocentric retrospective case-control study, using prospectively collected data, includes 60 patients who underwent, between 2022 and 2024, minimally invasive robot-assisted lobectomy or segmentectomy: 30 with TenaTac® vs. 30 with other devices. Data were extracted from Epithor, the French national database, with ethics committee validation.

Results: Patients characteristics, Index of Prolonged Air Leak, and surgical procedures were similar in both groups (NS). TenaTac® hemostatic benefit was comparable to other devices (p = 0.56). Prolonged air leak rate was significantly lower with TenaTac® (3%) than for control devices (37%) (p = 0.0004). Post-operative air leakage duration was significantly shorter in TenaTac® group than in control group (2.23 ± 2.57 vs. 4.23 ± 3.87 days, p = 0.01). Mean drainage duration and length of stay were both reduced with TenaTac® by 36 hours. No significant difference was observed between the two groups in terms of morbidity (90-day post-operative complications classified as Clavien-Dindo grade>II, p = 0.33), readmission rates (nil), or 90-day mortality (no deaths).

Conclusions: Numerous hemostatic or aerostatic devices have been previously evaluated without achieving consensus in the prevention of prolonged air leak. As an absorbable, adherent gelatine patch, TenaTac® significantly reduces the incidence of prolonged air leak after major lung resection.

目的:减少肺大切除术后出血和长时间漏气(bbb50天)仍然是一个挑战。止血和止血装置可以促进早期胸腔引流和快速通道。我们的目的是评估TenaTac®(一种被批准为医疗器械的弹性黏附贴片)在减少肺大切除术后出血和长时间漏气的疗效。方法:这项单中心回顾性病例对照研究,使用前瞻性收集的数据,包括60例在2022年至2024年间接受微创机器人辅助肺叶切除术或节段切除术的患者:30例使用TenaTac®,30例使用其他设备。数据提取自法国国家数据库上皮,并经伦理委员会验证。结果:两组患者特征、长时间漏气指数、手术方式相似(NS)。TenaTac®止血效果与其他器械相当(p = 0.56)。TenaTac®延长的漏气率(3%)显著低于对照装置(37%)(p = 0.0004)。TenaTac组术后漏气时间明显短于对照组(2.23±2.57∶4.23±3.87,p = 0.01)。使用TenaTac®后,平均引流时间和住院时间均减少了36小时。两组在发病率(术后90天并发症分类为Clavien-Dindo级>II, p = 0.33)、再入院率(零)或90天死亡率(无死亡)方面无显著差异。结论:许多止血或空气静压装置在预防长时间空气泄漏方面没有达成共识。作为一种可吸收的、粘附的明胶贴片,TenaTac®显著降低了大肺切除术后长时间漏气的发生率。
{"title":"Blood loss and prolonged air leak reduction by applying TenaTac<sup>®</sup> gelatine patch after major pulmonary minimal-invasive resection.","authors":"Caroline Rivera, Cyril Perrot, Florence Mazeres, Elodie Rive","doi":"10.1007/s11748-025-02194-3","DOIUrl":"10.1007/s11748-025-02194-3","url":null,"abstract":"<p><strong>Objective: </strong>Reduction of bleeding and prolonged air leak (>5 days) following major lung resection remains a challenge. Hemostasis and aerostasis devices can facilitate earlier pleural de-drainage and fast-track. Our objectives were to evaluate the efficacy of TenaTac<sup>®</sup> (an elastic, adhering patch approved as a medical device) in reducing bleeding and prolonged air leak after major lung resection.</p><p><strong>Methods: </strong>This monocentric retrospective case-control study, using prospectively collected data, includes 60 patients who underwent, between 2022 and 2024, minimally invasive robot-assisted lobectomy or segmentectomy: 30 with TenaTac<sup>®</sup> vs. 30 with other devices. Data were extracted from Epithor, the French national database, with ethics committee validation.</p><p><strong>Results: </strong>Patients characteristics, Index of Prolonged Air Leak, and surgical procedures were similar in both groups (NS). TenaTac<sup>®</sup> hemostatic benefit was comparable to other devices (p = 0.56). Prolonged air leak rate was significantly lower with TenaTac<sup>®</sup> (3%) than for control devices (37%) (p = 0.0004). Post-operative air leakage duration was significantly shorter in TenaTac<sup>®</sup> group than in control group (2.23 ± 2.57 vs. 4.23 ± 3.87 days, p = 0.01). Mean drainage duration and length of stay were both reduced with TenaTac<sup>®</sup> by 36 hours. No significant difference was observed between the two groups in terms of morbidity (90-day post-operative complications classified as Clavien-Dindo grade>II, p = 0.33), readmission rates (nil), or 90-day mortality (no deaths).</p><p><strong>Conclusions: </strong>Numerous hemostatic or aerostatic devices have been previously evaluated without achieving consensus in the prevention of prolonged air leak. As an absorbable, adherent gelatine patch, TenaTac<sup>®</sup> significantly reduces the incidence of prolonged air leak after major lung resection.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"278-285"},"PeriodicalIF":1.3,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12956910/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145033117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic comparison between superior and basal segments in pure-solid non-small cell lung cancer. 纯实性非小细胞肺癌上节段与基节段预后比较。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-01 Epub Date: 2025-09-18 DOI: 10.1007/s11748-025-02202-6
Shinji Yuhara, Masaaki Nagano, Yue Cong, Keita Nakao, Mitsuaki Kawashima, Gouji Toyokawa, Chihiro Konoeda, Yan Luo, Masaaki Sato

Objective: Studies suggest that non-small cell lung cancer of the superior segment (S6) affects different lymphatic pathways and results in worse prognosis than basal segment tumors. We aimed to compare survival after lobectomy between non-small cell lung cancer in the S6 and basal segments, focusing specifically on pure-solid tumors, which have higher lymph node metastasis rates and worse prognosis.

Methods: We retrospectively reviewed patients with pure-solid, clinical N0 M0, ≤ 5-cm, lower-lobe non-small cell lung cancer who underwent lobectomy with hilar and mediastinal lymphadenectomy between April 2009 and December 2021. Overall survival, recurrence-free survival and clinicopathological characteristics were evaluated.

Results: We categorized 157 patients into S6 (n = 58) and basal segment (n = 99) groups. The 5-year overall survival (66.4% vs. 68.6%, respectively; p = 0.519; hazard ratio, 1.19; 95% confidence interval, 0.70-2.03), and recurrence-free survival (54.8% vs. 65.5%, respectively; p = 0.452; hazard ratio, 1.22; 95% confidence interval, 0.72-2.06) rates were comparable between the S6 and basal segment groups. Multivariable Cox regression analyses indicated that tumor location was not associated with overall or recurrence-free survival. The S6 group showed a higher tendency for visceral pleural invasion compared with the basal segment group. Superior mediastinal lymph node metastasis was pathologically confirmed exclusively in the S6 group (two cases).

Conclusions: No significant difference in survival was observed between S6 and basal segment pure-solid non-small cell lung cancer after lobectomy with hilar and mediastinal lymph node dissection.

目的:研究表明,上段非小细胞肺癌(S6)影响不同的淋巴通路,其预后比基底段肿瘤差。我们的目的是比较S6和基底节段非小细胞肺癌肺叶切除术后的生存率,特别关注具有较高淋巴结转移率和较差预后的纯实体肿瘤。方法:回顾性分析2009年4月至2021年12月间,临床N0 M0,≤5 cm,下肺叶非小细胞肺癌行肺叶切除术并肺门和纵隔淋巴结切除术的患者。评估总生存期、无复发生存期和临床病理特征。结果:157例患者分为S6组(n = 58)和基底节段组(n = 99)。5年总生存率(66.4%比68.6%,p = 0.519; 95%可信区间,0.70-2.03)和无复发生存率(54.8%比65.5%,p = 0.452;风险比,1.22,95%可信区间,0.72-2.06)在S6组和基底段组之间具有可比性。多变量Cox回归分析表明,肿瘤位置与总生存率或无复发生存率无关。与基底段组相比,S6组有更高的内脏性胸膜侵犯倾向。病理证实上纵隔淋巴结转移仅在S6组(2例)。结论:S6与基底段纯实体非小细胞肺癌肺叶切除术合并肺门及纵隔淋巴结清扫后生存率无显著差异。
{"title":"Prognostic comparison between superior and basal segments in pure-solid non-small cell lung cancer.","authors":"Shinji Yuhara, Masaaki Nagano, Yue Cong, Keita Nakao, Mitsuaki Kawashima, Gouji Toyokawa, Chihiro Konoeda, Yan Luo, Masaaki Sato","doi":"10.1007/s11748-025-02202-6","DOIUrl":"10.1007/s11748-025-02202-6","url":null,"abstract":"<p><strong>Objective: </strong>Studies suggest that non-small cell lung cancer of the superior segment (S6) affects different lymphatic pathways and results in worse prognosis than basal segment tumors. We aimed to compare survival after lobectomy between non-small cell lung cancer in the S6 and basal segments, focusing specifically on pure-solid tumors, which have higher lymph node metastasis rates and worse prognosis.</p><p><strong>Methods: </strong>We retrospectively reviewed patients with pure-solid, clinical N0 M0, ≤ 5-cm, lower-lobe non-small cell lung cancer who underwent lobectomy with hilar and mediastinal lymphadenectomy between April 2009 and December 2021. Overall survival, recurrence-free survival and clinicopathological characteristics were evaluated.</p><p><strong>Results: </strong>We categorized 157 patients into S6 (n = 58) and basal segment (n = 99) groups. The 5-year overall survival (66.4% vs. 68.6%, respectively; p = 0.519; hazard ratio, 1.19; 95% confidence interval, 0.70-2.03), and recurrence-free survival (54.8% vs. 65.5%, respectively; p = 0.452; hazard ratio, 1.22; 95% confidence interval, 0.72-2.06) rates were comparable between the S6 and basal segment groups. Multivariable Cox regression analyses indicated that tumor location was not associated with overall or recurrence-free survival. The S6 group showed a higher tendency for visceral pleural invasion compared with the basal segment group. Superior mediastinal lymph node metastasis was pathologically confirmed exclusively in the S6 group (two cases).</p><p><strong>Conclusions: </strong>No significant difference in survival was observed between S6 and basal segment pure-solid non-small cell lung cancer after lobectomy with hilar and mediastinal lymph node dissection.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"301-308"},"PeriodicalIF":1.3,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12956945/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145085799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
General Thoracic and Cardiovascular Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1